Putting a ProSolus Partnership to Work for You

If your business is considering a molecule for transdermal patch development, we will proficiently evaluate the molecule to determine compatibility with our Transdermal Drug Delivery system.

Whether you need to assess molecules for an NCE opportunity or evaluate for a 505(b)(2) opportunity, we will promptly gauge API for transdermal patch suitability. We can accommodate small investigative supplies as well as provide pilot, pivotal, and commercial supplies.

Contact us for more information: (305) 514-0270